3.95
-0.05 (-1.25%)
Previous Close | 4.00 |
Open | 4.00 |
Volume | 44,400 |
Avg. Volume (3M) | 12,401 |
Market Cap | 585,840,320 |
Price / Earnings (TTM) | 14.63 |
Price / Earnings (Forward) | 11.61 |
Price / Sales | 2.49 |
Price / Book | 2.27 |
52 Weeks Range | |
TTM Dividend Yield | 6.46% |
Profit Margin | 16.98% |
Operating Margin (TTM) | 25.18% |
Diluted EPS (TTM) | 0.270 |
Quarterly Revenue Growth (YOY) | -5.40% |
Quarterly Earnings Growth (YOY) | -5.70% |
Total Debt/Equity (MRQ) | 0.22% |
Current Ratio (MRQ) | 2.33 |
Operating Cash Flow (TTM) | 54.47 M |
Levered Free Cash Flow (TTM) | -13.12 M |
Return on Assets (TTM) | 9.48% |
Return on Equity (TTM) | 15.02% |
Market Trend
Short Term | Medium Term | ||
Industry | Drug Manufacturers - Specialty & Generic (MY) | Mixed | Mixed |
Drug Manufacturers - Specialty & Generic (Global) | Mixed | Mixed | |
Stock | KOTRA | Mixed | Bearish |
AIStockmoo Score
Analyst Consensus | NA |
Insider Activity | NA |
Price Volatility | 4.5 |
Technical Moving Averages | 2.5 |
Technical Oscillators | -0.5 |
Average | 2.17 |
Kotra Industries Bhd is an investment holding company. Along with its subsidiaries, the company is engaged in research and development, manufacturing, and trading of pharmaceutical and healthcare products. Its product range includes nutraceutical and pharmaceutical products. It offers tablets, capsules, creams, and ointments under the brand names, Appeton, Axcel, AxPain, Creobic, Arite, and Vaxcel. The geographical segments of the company are based on the country in which its customers are located and include Malaysia and Overseas. It generates maximum revenue from Malaysia. |
|
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Investment Style | Small Value |
% Held by Insiders | 82.55% |
No data within this time range.
No data within this time range.
Date | Type | Details |
---|---|---|
02 Apr 2025 | TheEdge | Duopharma Biotech back on growth path as focus on revenue pays off |
28 Feb 2025 | Announcement | Change in Nomination Committee - MR PIONG CHEE KIEN |
28 Feb 2025 | Announcement | Change in Audit Committee - MR PIONG CHEE KIEN |
28 Feb 2025 | Announcement | Change in Audit Committee - MR PIONG CHEE KUAN |
28 Feb 2025 | Announcement | Change in Remuneration Committee - MR PIONG CHEE KUAN |
28 Feb 2025 | Announcement | Change in Nomination Committee - MR PIONG CHEE KUAN |
28 Feb 2025 | Announcement | Change in Remuneration Committee - MR PIONG CHEE KIEN |
28 Feb 2025 | Announcement | Change in Boardroom - MR PIONG CHEE KIEN |
19 Feb 2025 | Announcement | Quarterly rpt on consolidated results for the financial period ended 31/12/2024 |
31 Jan 2025 | Announcement | Change in Boardroom - MR PIONG CHEE KUAN |
TTM Dividend Yield | 6.46% |
5Y Average Dividend Yield | 4.71% |
Payout Ratio | 140.85% |
Expected Next Dividend Payment | Oct 2025 |
Ex Date | Announcement Date | Payment Date | Details |
---|---|---|---|
16 Dec 2024 | 27 Nov 2024 | 26 Dec 2024 | 0.125 Cash |
30 Sep 2024 | 19 Aug 2024 | 10 Oct 2024 | 0.13 Cash |
11 Mar 2024 | 21 Feb 2024 | 21 Mar 2024 | 0.125 Cash |
02 Oct 2023 | 23 Aug 2023 | 12 Oct 2023 | 0.155 Cash |
13 Mar 2023 | 24 Feb 2023 | 23 Mar 2023 | 0.1 Cash |
30 Nov 2022 | 06 Oct 2022 | 08 Dec 2022 | 0.16 Cash |
14 Mar 2022 | 24 Feb 2022 | 24 Mar 2022 | 0.095 Cash |
29 Nov 2021 | 06 Oct 2021 | 09 Dec 2021 | 0.07 Cash |
08 Mar 2021 | 19 Feb 2021 | 18 Mar 2021 | 0.02 Cash |
27 Nov 2020 | 02 Oct 2020 | 10 Dec 2020 | 0.045 Cash |
24 Feb 2020 | 05 Feb 2020 | 06 Mar 2020 | 0.045 Cash |
02 Dec 2019 | 10 Oct 2019 | 13 Dec 2019 | 0.044 Cash |
Show more |
Annual Dividend Yield
Year | Annual Dividend ($) | Frequency/Year | Yield % |
---|---|---|---|
2024 | 0.380 | 3 | 8.56 |
2023 | 0.255 | 2 | 5.28 |
2022 | 0.255 | 2 | 3.86 |
2021 | 0.090 | 2 | 2.85 |
2020 | 0.090 | 2 | 3.01 |
2019 | 0.044 | 1 | 2.34 |
Show more |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2025 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |